If one company received the royalty payouts on Pfizer’s COVID-19 mRNA nanotechnology sales alone it would likely be listed as a Fortune 500 company. Except, Pfizer isn’t paying anyone anytime soon.
Karen Kingston ..January 17, 2023 READ
Like this:
Like Loading...
Related
About michael burgwin
A child of the peace and antiWar movements, a Truther with self-diagnosed Opposition Defiance Disorder, formerly politically liberal tho now politically marooned, and Post-Doomer, on any issue, I trend to the conspiracy side, sort through the absurd, fantastical and insane, until I find firm ground usually located just the other side of the censorship firewall of propaganda and orthodoxy, dogma, and other either / or thinking.